TY - JOUR
T1 - Assessing clinical significance in measuring oncology patient quality of life
T2 - Introduction to the symposium, content overview, and definition of terms
AU - Clinical Significance Consensus Meeting Group
AU - Sloan, Jeff A.
AU - Cella, David
AU - Frost, Marlene
AU - Guyatt, Gordon H.
AU - Sprangers, Mirjam
AU - Symonds, Tara
AU - Aaronson, Neil
AU - Barofsky, Ivan
AU - Berzon, Rick
AU - Bonomi, Amy
AU - Bullinger, Monika
AU - Cappelleri, Joseph C.
AU - Fairclough, Diane
AU - Ferrans, Carol Estwing
AU - Hays, Ron D.
AU - Marquis, Patrick
AU - Moinpour, Carol M.
AU - Moynihan, Tim
AU - Norman, Geoff
AU - Osoba, David
AU - Patrick, Donald
AU - Revicki, Dennis
AU - Rummans, Teresa
AU - Scott, Charles
AU - Varricchio, Claudette
AU - Wong, Gilbert
AU - Wu, Albert
AU - Wyrwich, Kathleen
PY - 2002
Y1 - 2002
N2 - The Clinical Significance Consensus Meeting Group of the Symposium on the Clinical Significance of Quality-of-Life Measures in Cancer Patients produced 6 articles regarding the clinical significance of quality of life (QOL) assessments in oncology. The 6 articles deal with the methods used to date: group-vs-individual clinical significance; single items vs summated scores; patient, clinician, and population perspectives; assessment of changes over time; and communication of results. The articles were produced by a team of 30 QOL research experts assembled in a consensus writing meeting held at the Mayo Clinic, Rochester, Minn, October 6 and 7, 2000. This introduction describes the need for the articles, definitions of key terms, and plans for the future. It is hoped that this series of articles will serve as a resource for individuals conducting cancer QOL research and for clinicians considering incorporation of QOL assessment in the treatment of patients with neoplastic diseases. A secondary goal is to stimulate further discussion and research in the interpretation of QOL assessments.
AB - The Clinical Significance Consensus Meeting Group of the Symposium on the Clinical Significance of Quality-of-Life Measures in Cancer Patients produced 6 articles regarding the clinical significance of quality of life (QOL) assessments in oncology. The 6 articles deal with the methods used to date: group-vs-individual clinical significance; single items vs summated scores; patient, clinician, and population perspectives; assessment of changes over time; and communication of results. The articles were produced by a team of 30 QOL research experts assembled in a consensus writing meeting held at the Mayo Clinic, Rochester, Minn, October 6 and 7, 2000. This introduction describes the need for the articles, definitions of key terms, and plans for the future. It is hoped that this series of articles will serve as a resource for individuals conducting cancer QOL research and for clinicians considering incorporation of QOL assessment in the treatment of patients with neoplastic diseases. A secondary goal is to stimulate further discussion and research in the interpretation of QOL assessments.
UR - http://www.scopus.com/inward/record.url?scp=0036195744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036195744&partnerID=8YFLogxK
U2 - 10.4065/77.4.367
DO - 10.4065/77.4.367
M3 - Article
C2 - 11936934
AN - SCOPUS:0036195744
SN - 0025-6196
VL - 77
SP - 367
EP - 370
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 4
ER -